Skip to main content

Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic β Cell Proliferation.

Citation
Shirakawa, J., et al. “Insulin Signaling Regulates The Foxm1/Plk1/Cenp-A Pathway To Promote Adaptive Pancreatic Β Cell Proliferation.”. Cell Metabolism, pp. 868-882.e5.
Center Joslin Diabetes Center
Author Jun Shirakawa, Megan Fernandez, Tomozumi Takatani, Abdelfattah El Ouaamari, Prapaporn Jungtrakoon, Erin R Okawa, Wei Zhang, Peng Yi, Alessandro Doria, Rohit N Kulkarni
Keywords CENP-A, FoxM1, M-phase, PLK1, Apoptosis, cell cycle, cell proliferation, human islets, Insulin receptor signaling, type 2 diabetes, β
Abstract

Investigation of cell-cycle kinetics in mammalian pancreatic β cells has mostly focused on transition from the quiescent (G0) to G1 phase. Here, we report that centromere protein A (CENP-A), which is required for chromosome segregation during the M-phase, is necessary for adaptive β cell proliferation. Receptor-mediated insulin signaling promotes DNA-binding activity of FoxM1 to regulate expression of CENP-A and polo-like kinase-1 (PLK1) by modulating cyclin-dependent kinase-1/2. CENP-A deposition at the centromere is augmented by PLK1 to promote mitosis, while knocking down CENP-A limits β cell proliferation and survival. CENP-A deficiency in β cells leads to impaired adaptive proliferation in response to pregnancy, acute and chronic insulin resistance, and aging in mice. Insulin-stimulated CENP-A/PLK1 protein expression is blunted in islets from patients with type 2 diabetes. These data implicate the insulin-FoxM1/PLK1/CENP-A pathway-regulated mitotic cell-cycle progression as an essential component in the β cell adaptation to delay and/or prevent progression to diabetes.

Year of Publication
2017
Journal
Cell metabolism
Volume
25
Issue
4
Number of Pages
868-882.e5
Date Published
04/2017
ISSN Number
1932-7420
DOI
10.1016/j.cmet.2017.02.004
Alternate Journal
Cell Metab.
PMID
28286049
PMCID
PMC5382039
Download citation